Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport pilot study in neurogenic detrusor overactivity
2010-023210-31Phase 2Completed
- Sponsor
- Ipsen
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, double-blind trial of botulinum toxin type A in detrusor hyperreflexia (DH) (4 arms), sponsored by Ipsen. Primary endpoint: Mean change from baseline in averaged daily urinary incontinence episode frequency. Started Nov 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
detrusor hyperreflexia (DH)
Beyond the preview
Go deeper on 2010-023210-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023210-31.